<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150825023760N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-02-22</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of hydrocortisone, vitamin C, and thiamine for treatment of  septic shock</public_title>
      <acronym></acronym>
      <scientific_title>The effect of hydrocortisone , vitamin C, and thiamine for treatment of patients with septic shock addmited to intensive care unit of Ayatollah Mousavi  hospital in Zanjan , in 2017-18</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-05-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>58</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/31599</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study patients who met inclusion criteria were divided into intervention and control group by simple randomization method. Fiftyeghit patients with diagnosis of septic shock in critical care unit of ayatollah mousavi hospital after matching for demographic data’s and Apache 2 Score we’re divided into intervention group and control group by randomization with computerized random number tables.This method is one of  basic methods for sampling in experimental studies, and frequently is used in studies with a few sample size.For randomization between two groups, random  numbers table is used.In this study fiftyeghit patients with diagnosis of septic shock in critical care unit of ayatollah mousavi hospital after matching for demographic data’s and Apache 2 Score we’re divided into intervention group and control group by randomization with computerized random number tables.Fifty eight random numbers were extracted of computer by using random number table and for example 24th sample was set in intervention group and 14th sample  was set in control group and this process was performed until end of the study.</study_design>
      <phase>3</phase>
      <hc_freetext>Septic shock.</hc_freetext>
      <i_freetext>Intervention 1: Intervention  group: This group has received the assessed combination therapy, including hydrocortisone (50mg/each 6h, intravenously), vitamin C (1.5g/6h in 100ml  DW5%, intravenously), and thiamine (200mg/12h in 50ml  DW5%, intravenously)in addition to standard septic shock treatment protocols for seventy two hours. Intervention 2: Control group: This group has treated by standard  septic shock  treatment protocols including  antibiotic therapy, prophylaxis of deep venous thrombosis, sedative medications, mechanical ventilation and prescription of vasopressor without additional intervention .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After the end of study,We will share non-identifiable individual data of the participants, the study protocol, the statistical analysis of the data, the informed consent form  patients,clinical reports, analysis codes, and data coding systems (data Dictionary) .

When:
We will share our study  results in 2019.

To whom:
The data from this study will be available to all people who can play a role in caring of septic patients, such as families, and healthcare workers.

Conditions:
The results of this study will be useful for care providers especially  involving in septic patients admitted to intensive care units.

Where to obtain:
To receive information anyone can be use the following email: jamshidianes@zums.ac.ir

How to obtain:
we will send the results of our study to the applicants .

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Jamshidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mousavy Hospital, Sobotie Blvd, Zanjan</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4513956183</zip>
        <telephone>+98 24 3313 0000</telephone>
        <email>jamshidianes@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Jamshidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zanjan,Gavazang Ave ,Mousavy Hospital</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4513956183</zip>
        <telephone>+98 24 3313 0000</telephone>
        <email>jamshidianes@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients with septic shock and the same Acute Physiology, Age, chronic health evaluation II (APACHE II score) admitted to intensive care unit
Intubated patients
Age between  18 to 70 years
Serum pro-calcitonin level ≥ 2ng/ml.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnant patients</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R65.21</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Severe sepsis with septic shock</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention  group: This group has received the assessed combination therapy, including hydrocortisone (50mg/each 6h, intravenously), vitamin C (1.5g/6h in 100ml  DW5%, intravenously), and thiamine (200mg/12h in 50ml  DW5%, intravenously)in addition to standard septic shock treatment protocols for seventy two hours.</i_keyword>
      <i_keyword>Control group: This group has treated by standard  septic shock  treatment protocols including  antibiotic therapy, prophylaxis of deep venous thrombosis, sedative medications, mechanical ventilation and prescription of vasopressor without additional intervention .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The Sequential organ function assessment (SOFA) score:a factor for   evaluation of organ function. Timepoint: One day Later-Three days Later. Method of measurement: SOFA table was used to measure the performance of the organs.</prim_outcome>
      <prim_outcome>Serum lactate( a factor for evaluation of Oran perfusion). Timepoint: One day Later-Three days Later. Method of measurement: Lactate measurement kit was used to measure lactate.</prim_outcome>
      <prim_outcome>WBC count(leukocyte Count as a factor for evaluation of sepsis  progression). Timepoint: One day Later-Three days Later. Method of measurement: Cell counters were used to measure the number of white blood cells.</prim_outcome>
      <prim_outcome>Need for vasopressors (definition  of septic shock is sepsis which   requires treatment with vasopressors). Timepoint: One day later-Three days later. Method of measurement: For measuring the vasopressors, the average pressure is used, the unit is micrograms per minute.</prim_outcome>
      <prim_outcome>Serum procalcitonin (indicator of sepsis severity). Timepoint: One day later-Three days later. Method of measurement: The measure of procalcitonin was VIDAS B.R.A.M.S PCT assy.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-05-28</approval_date>
        <contact_name>Ethics committee of Zanjan University of Medical  Sciences</contact_name>
        <contact_address>Mousavi hospital,Sobotie Blvd, Zanjan Zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
